Literature DB >> 18312809

Discontinuation of nicotine replacement therapy among smoking-cessation attempters.

Emily K Burns1, Arnold H Levinson.   

Abstract

BACKGROUND: Nicotine replacement therapy (NRT) doubles successful quitting, but more than half of NRT users do not comply with optimal treatment regimens.
METHODS: From the 2005 Colorado state tobacco survey, quit attempters who utilized NRT (N=366) were analyzed in spring 2007. Descriptive and regression analyses were used to examine reasons for discontinuing NRT, length of time on NRT, and quit intentions.
RESULTS: The reasons for discontinuing NRT were resuming smoking (34%), side effects (17%), NRT not helping with quitting (14%), quitting smoking (10%), and cost (5%). Poverty, age, and non-Latino minority status were associated with reasons for discontinuation other than quitting smoking. Having side effects was associated with a short duration of NRT use and 95% lower odds of intending to quit in the next month.
CONCLUSIONS: In the first population-level study examining reasons for discontinuing NRT, general-population smokers who initiate NRT use when attempting to quit are highly likely to discontinue NRT prematurely. Age and culturally-appropriate medication management interventions may increase NRT compliance and improve cessation outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312809     DOI: 10.1016/j.amepre.2007.11.010

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  34 in total

1.  Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse.

Authors:  Tanya R Schlam; Timothy B Baker; Stevens S Smith; Daniel M Bolt; Danielle E McCarthy; Jessica W Cook; Todd Hayes-Birchler; Michael C Fiore; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

2.  A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.

Authors:  Elyse R Park; Sandra Japuntich; Jennifer Temel; Michael Lanuti; Jennifer Pandiscio; Joanna Hilgenberg; Diane Davies; Carolyn Dresler; Nancy A Rigotti
Journal:  J Thorac Oncol       Date:  2011-06       Impact factor: 15.609

3.  Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.

Authors:  James Balmford; Ron Borland; David Hammond; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2010-12-08       Impact factor: 4.244

4.  Interventions to increase adherence to medications for tobacco dependence.

Authors:  Gareth J Hollands; Felix Naughton; Amanda Farley; Nicola Lindson; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

Review 5.  Pharmacotherapy for smoking cessation: current advances and research topics.

Authors:  Tobias Raupach; Constant P van Schayck
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

6.  Reaching Spanish-speaking smokers: state-level evidence of untapped potential for QuitLine utilization.

Authors:  Emily K Burns; Arnold H Levinson
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

7.  Smoking Cessation Treatment Needs of Low SES Cervical Cancer Survivors.

Authors:  Diana S Hoover; Claire A Spears; Damon J Vidrine; Joan L Walker; Ya-Chen Tina Shih; David W Wetter
Journal:  Am J Health Behav       Date:  2019-05-01

8.  Predictors of Adherence to Nicotine Replacement Therapy (Nicotine Patch) Among Homeless Persons Enrolled in a Randomized Controlled Trial Targeting Smoking Cessation.

Authors:  O Ojo-Fati; J L Thomas; R I Vogel; O Ogedegbe; G Jean-Louis; K S Okuyemi
Journal:  J Fam Med       Date:  2016-09-06

9.  Treatment adherence in a lay health adviser intervention to treat tobacco dependence.

Authors:  N E Hood; A K Ferketich; E D Paskett; M E Wewers
Journal:  Health Educ Res       Date:  2012-07-28

10.  Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

Authors:  David Gonzales; Douglas E Jorenby; Thomas H Brandon; Carmen Arteaga; Theodore C Lee
Journal:  Addiction       Date:  2010-09-01       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.